Jonathan S. Wolin serves as Executive at Jaguar Health, Inc., where they oversee executive responsibilities. Since joining the company, Jonathan S. Wolin has executed 7 insider transactions totaling $10, demonstrating a bullish approach to their equity position. Their most recent transaction on May 17, 2024 involved exercising options for 871 shares valued at $0.
Jonathan S. Wolin currently holds 2,012 shares of Jaguar Health, Inc. (JAGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan S. Wolin has been a net buyer of JAGX stock. They have purchased $10 and sold $0 worth of shares.
Jonathan S. Wolin's most recent insider trade was on May 17, 2024, when they sold 871 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 89 |
| $N/A |
| Discretionary |
| Aug 14, 2023 | JAGX | $0 | Award | 196,628 | $N/A | Discretionary |
| May 17, 2023 | JAGX | $0 | Option Exercise | 871 | $N/A | Discretionary |
| Apr 5, 2023 | JAGX | $0 | Option Exercise | 88 | $N/A | Discretionary |
| Dec 31, 2022 | JAGX | $10 | Purchase | 317 | $0.03 | Discretionary |
| Apr 5, 2022 | JAGX | $0 | Option Exercise | 6,666 | $N/A | Discretionary |